<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03838549</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0244 UF 7672</org_study_id>
    <nct_id>NCT03838549</nct_id>
  </id_info>
  <brief_title>Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy</brief_title>
  <acronym>MRIMOP</acronym>
  <official_title>Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>association la montpellier reine a du coeur</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Implant-based reconstruction is currently the most common choice for mastectomy
      reconstruction. Whatever the choice of mastectomy incision, a scar remains on or near the
      breast volume. Current techniques involve partial or total coverage of the implant with the
      pectoralis major muscle, to prevent exposure or infection. The muscle dissection technique
      applied has functional and cosmetic consequences. In this study, an endoscopic approach will
      be evaluated. This new surgical technique, using a single-port endoscopic way, will put the
      scar is in the axillary area, away from the breast. The hypothesis is that this delocalized
      scar potentially reduces the risk of exposure and allows placement of the implant in the
      subcutaneous space, with no manipulation of the pectoralis major muscle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It s a practicability study, evaluating endoscopic approach for prophylactic mastectomy,
      using an axillary single port. Classic open surgery conversion rate, operative time,
      infectious rate, esthetical outcomes, and functional outcomes will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 26, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate of total mastectomy</measure>
    <time_frame>one day</time_frame>
    <description>the total mastectomy is done by a scar in the axillary area, away from the breast, using single port endoscopy, with Implant base reconstruction in pre pectoral position.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>one day</time_frame>
    <description>duration of the prophylactic mastectomy with immediate breast reconstruction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Open surgery conversion rate</measure>
    <time_frame>one day</time_frame>
    <description>Open surgery conversion rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with an infection</measure>
    <time_frame>2 months after the prophylactic mastectomy</time_frame>
    <description>Number of participants with early postoperative infection two months after the prophylactic mastectomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>one day</time_frame>
    <description>blood loss (milliliters) during the prophylactic mastectomy with immediate breast reconstruction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with a local haematoma</measure>
    <time_frame>between the day of the prophylactic mastectomy and a month later</time_frame>
    <description>Number of participants with a local haematoma caused by the prophylactic mastectomy with immediate breast reconstruction</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Genetic Predisposition</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>implant for breast reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 patients female with genetic risk for breast cancer and who ask for prophylactic mastectomy. They will have a prophylactic mastectomy with immediate breast reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prophylactic mastectomy with immediate breast reconstruction</intervention_name>
    <description>It is an endoscopic approach for prophylactic mastectomy using an axillary single port</description>
    <arm_group_label>implant for breast reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Genetic risk factors for breast cancer

          -  Ask for prophylactic mastectomy

          -  World Heath Organization score &lt;3

          -  Glandular volume : bonnets A, B ou C

          -  Glandular ptosis &lt;=2 (Classification and Algorithm for Treatment of Breast Ptosis)

          -  Contraception

          -  No pregnancy

          -  Valid Social Security

          -  Wrote consent

        Exclusion Criteria:

          -  History of breast cancer surgery

          -  Breast cancer not operated

          -  Patient with irradiant treatment

          -  Breast hypertrophy

          -  Smoking &gt; 10 cigarette/day

          -  obesity

          -  Large breast volume requiring prostheses &gt; 500ml

          -  Chronic pulmonary obstructive gold 4

          -  Chronic shoulder pain on the side to operate, or both shoulders

          -  history of abarticular pathology of the shoulder on the operating side
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gauthier Rathat, MD</last_name>
    <phone>0467336532</phone>
    <email>g-rathat@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <state>HÃ©rault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gauthier Rathat, MD</last_name>
      <phone>0467336532</phone>
      <email>g.rathat@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 8, 2019</study_first_submitted>
  <study_first_submitted_qc>February 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>March 11, 2020</last_update_submitted>
  <last_update_submitted_qc>March 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prophylactic Surgical Procedure</keyword>
  <keyword>Subcutaneous Mastectomy</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Breast Reconstruction</keyword>
  <keyword>Breast Implants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

